ATORVASTATIN CALCIUM
These highlights do not include all the information needed to use ATORVASTATIN CALCIUM TABLETS safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM TABLETS. ATORVASTATIN CALCIUM tablets, for oral use Initial U.S. Approval: 1996
f2d8b5e9-6ff2-4efa-ab01-e13df29f7371
HUMAN PRESCRIPTION DRUG LABEL
Nov 8, 2023
ScieGen Pharmaceuticals, Inc.
DUNS: 079391286
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ATORVASTATIN CALCIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
ATORVASTATIN CALCIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
ATORVASTATIN CALCIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
ATORVASTATIN CALCIUM
Product Details
FDA regulatory identification and product classification information